Delivery Order 75F40124D00043-75F40124F19001

Award Date 9/27/24
Potential Completion Date 9/29/25
Potential Value $6.2M
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Time and Materials
Place of Performance
Falls Church, VA 22042, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
4
Legislative Mandate
Service Contract Act
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order awarded to Iqvia Government Solutions Inc. under the Biologics Effectiveness and Safety (BEST) Initiative #3: Data Sources for Surveillance of Biologics indefinite delivery, indefinite quantity (IDIQ) contract with the Food and Drug Administration (FDA). The $17,498,031.84 award will provide data sources to conduct surveillance of biologics, covering tens of millions of patients from insurers, payers, and providers. The BEST Initiative IDIQ is valued at $50 million and...
The Department of Health and Human Services Food and Drug Administration awarded a $5,273,171.50 delivery order contract to Iqvia Government Solutions Inc. to conduct surveillance activities for the safety and effectiveness of biologics. This contract is part of the BEST Initiative, a larger indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle for data tools and infrastructure to support surveillance of biologics. Iqvia Government Solutions is a for-profit organization that has...
This is a $2,442,983.29 time-and-materials contract awarded by the Department of Health and Human Services Food and Drug Administration (FDA) to Iqvia Government Solutions Inc., a for-profit provider of healthcare data, analytics, and related services to federal agencies. The contract is for the Biologics Effectiveness and Safety (BEST) Initiative, which involves blood and blood products safety surveillance. No set-aside was used. Iqvia has held several past and current IDIQ contracts with the...
The Department of Health and Human Services Food and Drug Administration awarded a $2.68 million delivery order against the BEST Initative - Data Sources For Surveillance of Biologics master IDIQ to Iqvia Government Solutions Inc. The one-year order, with a period of performance from September 2020 through September 2021, will provide products and services in support of the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS effort. Under a time...
This federal contract award was issued by the Food and Drug Administration (FDA) to International Business Machines Corporation (IBM) to support the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative. The $8,234,421.12 delivery order contract will develop new and innovative methods for automated reporting for CBER-regulated biologics. The contract is a Time and Materials (T&M) type and does not have a set-aside designation. IBM will be...
The Department of Health and Human Services Food and Drug Administration (HHS FDA) awarded a $13.2 million delivery order contract to International Business Machines Corporation (IBM) under the Biologics Effectiveness and Safety (BEST) Initiative - Data Tools and Infrastructure for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract vehicle. The contract calls for IBM to provide data, tools, and infrastructure to support HHS FDA's BEST Initiative for surveillance of...
This federal contract was awarded by the Department of Health and Human Services Food and Drug Administration to the International Business Machines Corporation (IBM) on September 24, 2019. The $5,622,942.08 time and materials contract is a delivery order under the BEST Initiative - Data Tools and Infrastructure for Surveillance of Biologics master IDIQ contract vehicle. The objective is for IBM to conduct surveillance activities to assess the safety and effectiveness of biologics. This work...
The Food and Drug Administration (FDA) awarded a $24,583,221.15 delivery order contract to The Lewin Group, Inc. (a subsidiary of UnitedHealth Group Incorporated), to support the BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS. This contract is a task order under the $50 million BEST Initiative - Data Sources for Surveillance of Biologics indefinite-delivery/indefinite-quantity (IDIQ) contract, which provides longitudinal data sources needed to...
This is a delivery order awarded by the Food and Drug Administration (FDA) to CVS Healthspire Payor & Life Sciences LLC, a subsidiary of CVS Health Corporation, for the CENTER FOR BIOLOGICS EVALUATION AND RESEARCH (CBER) REQUIREMENT FOR BIOLOGICS EFFECTIVENESS AND SAFETY (BEST) INITIATIVE #3: HEALTH CARE DATA SOURCES FOR SURVEILLANCE OF BIOLOGICS (BEST 3). The contract is a time and materials agreement with a ceiling value of $1,381,573.96 and a period of performance through September 29,...
Iqvia Government Solutions Inc. was awarded a firm fixed price purchase order contract valued at $2,171,621.71 by the Department of Health and Human Services' Food and Drug Administration to obtain access to data resources enabling global capture of pharmaceutical sales data by country. This contract delivers against the original solicitation requesting pharmaceutical sales information to support the FDA in monitoring drug markets internationally. It was awarded without a set-aside designation...
  • 75F40124D00043
    Indefinite Delivery Contract
  • 75F40124D00043-75F40124F19001
    Delivery Order

This is a $6,155,378.96 time and materials contract awarded by the Food and Drug Administration (FDA) to Iqvia Government Solutions Inc. for the Center for Biologics Evaluation and Research (CBER) Biologics Effectiveness and Safety (BEST) Initiative #3: Health Care Data Sources for Surveillance of Biologics (BEST 3). The contract, which runs through September 29, 2025, is not set aside. Iqvia, a leading provider of healthcare data, analytics, and related services to federal agencies, will provide data sources to support the FDA's post-market surveillance of biologics. This award is part of a larger $50 million multiple-award Indefinite Delivery Vehicle (IDV) the FDA has with Iqvia for the BEST Initiative, which aims to enhance the agency's ability to monitor the safety and effectiveness of regulated biological products.

Generated 9/28/24, 10:40 AM